Nanomedicine for Drug Delivery across Epithelial Barriers: Intestines, Skin and Lungs
Helmholtz Institute of Pharmaceutical Research, Saarland University, Saarbrücken Germany
Sci. Pharm. 2010, 78(3), 545; https://doi.org/10.3797/scipharm.cespt.8.L05
Submission received: 12 July 2010
/
Accepted: 12 July 2010
/
Published: 12 July 2010
Abstract
Inflammatory bowel diseases, such as Morbus Crohn or Colitis Ulcerosa, are painful for the patient and moreover difficult to treat due to the increased mucus production and the occurrence of diarrhea. [...]
Share and Cite
MDPI and ACS Style
LEHR, C.-M. Nanomedicine for Drug Delivery across Epithelial Barriers: Intestines, Skin and Lungs. Sci. Pharm. 2010, 78, 545. https://doi.org/10.3797/scipharm.cespt.8.L05
AMA Style
LEHR C-M. Nanomedicine for Drug Delivery across Epithelial Barriers: Intestines, Skin and Lungs. Scientia Pharmaceutica. 2010; 78(3):545. https://doi.org/10.3797/scipharm.cespt.8.L05
Chicago/Turabian StyleLEHR, C.-M. 2010. "Nanomedicine for Drug Delivery across Epithelial Barriers: Intestines, Skin and Lungs" Scientia Pharmaceutica 78, no. 3: 545. https://doi.org/10.3797/scipharm.cespt.8.L05
